Tango Therapeutics Inc (TNGX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2020 | 12-2019 | 12-2017 | 12-2006 | |
| Cash Flows From Operating Activities | ||||
| Net Income | -51,972 | N/A | N/A | N/A |
| Depreciation Amortization | 718 | N/A | N/A | N/A |
| Accounts receivable | -2,000 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 1,171 | N/A | N/A | N/A |
| Other Working Capital | 118,674 | N/A | N/A | N/A |
| Other Operating Activity | 3,483 | 0 | 0 | 0 |
| Operating Cash Flow | $70,074 | $N/A | $N/A | $N/A |
| Cash Flows From Investing Activities | ||||
| PPE Investments | -1,106 | N/A | N/A | N/A |
| Purchase Of Investment | -207,540 | N/A | N/A | N/A |
| Sale Of Investment | 63,220 | N/A | N/A | N/A |
| Other Investing Activity | -40 | 0 | 0 | 0 |
| Investing Cash Flow | $-145,466 | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | ||||
| Common Stock Issued | 40 | N/A | N/A | N/A |
| Other Financing Activity | 80,844 | 0 | 0 | 0 |
| Financing Cash Flow | $80,884 | $N/A | $N/A | $N/A |
| Beginning Cash Position | 25,168 | N/A | N/A | N/A |
| End Cash Position | 30,660 | N/A | N/A | N/A |
| Net Cash Flow | $5,492 | $N/A | $N/A | $N/A |
| Free Cash Flow | ||||
| Operating Cash Flow | 70,074 | N/A | N/A | N/A |
| Capital Expenditure | -1,106 | N/A | N/A | N/A |
| Free Cash Flow | 68,968 | 0 | 0 | 0 |